These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 9041182
41. Increase in the frequency of p16INK4 gene inactivation by hypermethylation in lung cancer during the process of metastasis and its relation to the status of p53. Seike M, Gemma A, Hosoya Y, Hemmi S, Taniguchi Y, Fukuda Y, Yamanaka N, Kudoh S. Clin Cancer Res; 2000 Nov; 6(11):4307-13. PubMed ID: 11106248 [Abstract] [Full Text] [Related]
43. Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Hangaishi A, Ogawa S, Imamura N, Miyawaki S, Miura Y, Uike N, Shimazaki C, Emi N, Takeyama K, Hirosawa S, Kamada N, Kobayashi Y, Takemoto Y, Kitani T, Toyama K, Ohtake S, Yazaki Y, Ueda R, Hirai H. Blood; 1996 Jun 15; 87(12):4949-58. PubMed ID: 8652807 [Abstract] [Full Text] [Related]
45. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. Perrone F, Tabano S, Colombo F, Dagrada G, Birindelli S, Gronchi A, Colecchia M, Pierotti MA, Pilotti S. Clin Cancer Res; 2003 Sep 15; 9(11):4132-8. PubMed ID: 14519636 [Abstract] [Full Text] [Related]
46. Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocations. Maloney KW, McGavran L, Odom LF, Hunger SP. Leukemia; 1998 Sep 15; 12(9):1417-21. PubMed ID: 9737691 [Abstract] [Full Text] [Related]
47. Hypermethylation of p16(INK4a) and p15(INK4b) genes in non-small cell lung cancer. Kurakawa E, Shimamoto T, Utsumi K, Hirano T, Kato H, Ohyashiki K. Int J Oncol; 2001 Aug 15; 19(2):277-81. PubMed ID: 11445839 [Abstract] [Full Text] [Related]
48. Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors. Obana K, Yang HW, Piao HY, Taki T, Hashizume K, Hanada R, Yamamoto K, Tanaka Y, Toyoda Y, Takita J, Tsuchida Y, Hayashi Y. Int J Oncol; 2003 Oct 15; 23(4):1151-7. PubMed ID: 12963998 [Abstract] [Full Text] [Related]
49. [Homozygous deletion and methylation of p16 and p15 gene in acute leukemia]. Chen W, Zhang W, Zhu J. Zhonghua Xue Ye Xue Za Zhi; 1999 Sep 15; 20(9):474-6. PubMed ID: 11721412 [Abstract] [Full Text] [Related]
50. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors. Lubomierski N, Kersting M, Bert T, Muench K, Wulbrand U, Schuermann M, Bartsch D, Simon B. Cancer Res; 2001 Aug 01; 61(15):5905-10. PubMed ID: 11479232 [Abstract] [Full Text] [Related]
51. Cylin/CDK inhibitors of the 9p21 chromosomal region and hematological malignancies. Quesnel B. Bull Cancer; 1998 Sep 01; 85(9):747. PubMed ID: 9770602 [Abstract] [Full Text] [Related]
52. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes. Uchida T, Kinoshita T, Nagai H, Nakahara Y, Saito H, Hotta T, Murate T. Blood; 1997 Aug 15; 90(4):1403-9. PubMed ID: 9269757 [Abstract] [Full Text] [Related]
53. p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia. Kusy S, Larsen CJ, Roche J. Leuk Lymphoma; 2004 Oct 15; 45(10):1989-94. PubMed ID: 15370242 [Abstract] [Full Text] [Related]
54. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells. Schwaller J, Pabst T, Koeffler HP, Niklaus G, Loetscher P, Fey MF, Tobler A. Leukemia; 1997 Jan 15; 11(1):54-63. PubMed ID: 9001419 [Abstract] [Full Text] [Related]
55. Establishment of a novel human B-cell line (OZ) with t(14;18)(q32;q21) and aberrant p53 expression was associated with the homozygous deletions of p15INK4B and p16INK4A genes. Nagai M, Fujita M, Ohmori M, Matsubara S, Taniwaki M, Horiike S, Tasaka T, Koeffler HP, Takahara J. Hematol Oncol; 1997 Aug 15; 15(3):109-19. PubMed ID: 9600110 [Abstract] [Full Text] [Related]
56. [Expression of p16INK4a, p15INK4b, p21WAF1/Clip1 cell cycle inhibitors on blastic cells in patients with acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL) ]. Kapelko-Słowik K, Wołowiec D, Sedek K, Jaźwiec B, Urbaniak-Kujda D, Kuliczkowski K. Pol Arch Med Wewn; 2002 Sep 15; 108(3):849-53. PubMed ID: 12600181 [Abstract] [Full Text] [Related]
57. Different incidence and pattern of p15INK4b and p16INK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas. García MJ, Martínez-Delgado B, Cebrian A, Martínez A, Benítez J, Rivas C. Am J Pathol; 2002 Sep 15; 161(3):1007-13. PubMed ID: 12213729 [Abstract] [Full Text] [Related]
58. Cumulation of TP53 mutations and p16INK4A/p15INK4B homozygous deletions in human papilloma virus type 16 positive scrotal cancer. Güran S, Pak I. Cancer Genet Cytogenet; 1999 Mar 15; 109(2):108-13. PubMed ID: 10087941 [Abstract] [Full Text] [Related]
59. Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes. Aoki E, Uchida T, Ohashi H, Nagai H, Murase T, Ichikawa A, Yamao K, Hotta T, Kinoshita T, Saito H, Murate T. Leukemia; 2000 Apr 15; 14(4):586-93. PubMed ID: 10764143 [Abstract] [Full Text] [Related]
60. Hypermethylation of p16INK4A gene promoter during the progression of plasma cell dyscrasia. Uchida T, Kinoshita T, Ohno T, Ohashi H, Nagai H, Saito H. Leukemia; 2001 Jan 15; 15(1):157-65. PubMed ID: 11243384 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]